An innovative project of Mount Sinai Medical Center in New York City, HepCure is improving provider knowledge & patient engagement for chronic disease management in persons infected with the Hepatitis C Virus (HCV). The toolkit is designed to address barriers for the effective care and treatment of HCV by providing web-based and smartphone enabled resources, navigation, consultation, and support for both patients and providers. The HepCure toolkit draws upon the experience of expert providers within the Mount Sinai Network, with support and development by Sinai AppLab, Mount Sinai Medical Center. HepCure was developed by the Mount Sinai Division of Liver Diseases, Division of General Internal Medicine, and the Informatics for Research, Outcomes, and Quality initiative in the Division of Gastroenterology.
HepCure is a secure, cloud-based provider portal meant to virtually navigate providers through hepatitis C virus (HCV) care. The HepCure dashboard integrates tools to more effectively manage HCV infected patients. A flexible, scalable platform, the HepCure Dashboard provides a seamless flow of information within a digital healthcare infrastructure. HepCure enables easy access to HCV resources and best-practices for optimal management of HCV patients with the opportunity to engage patients on treatment, while improving overall health outcomes. The platform serves as an organizational tool, with built-in workflow efficiencies that optimize treatment decisions, reduce redundancies, as well as promote provider training and development.
Through the use of the dashboard and patient app, providers can:
We at HepCure are always looking for ways to improve. That’s why we’re constantly working on new features and meeting new challenges! Here are just a few of the features we plan to explore:
The patient app is a free resource for patients with hepatitis C, which allows them to track medication adherence, symptoms, and gain access to resources. It is available to download for free on iOS (App Store) and Android (Google Play) operating systems. While the app can be used by patients independently from the dashboard, it can also be linked with the provider dashboard. Providers can push lab data to patients and track treatment adherence and symptom data input by patients in real time.
The HepCure Tele-Education Webinar Series features many diverse and salient topics in hepatitis C. Each week, the webinar series showcases different speakers who are prominent members of the hepatitis C community. Our webinars are attended by a wide audience, and include providers, patient navigators, and other health workers from around the globe. Our collaboration with the New York State Clinical Education Initiative (CEI) and Empire Liver Foundation (ELF) allows us to provide continuing education credits (CME/CNE) through attendance to our webinars on the first and last Tuesday of every month.
All webinars are held on Tuesdays from 4:30 - 5:30pm EST
On Tuesday, July 9th, Dr. Daniel Fierer of the Icahn School of Medicine at Mount Sinai presented on: “Treat Now or Wait? Acute HCV Infection”
1. Explain the epidemiology of the hepatitis C virus (HCV).
2. Discuss laboratory testing and diagnosis of HCV infection.
3. Design a therapeutic regimen and monitoring plan for the treatment of HCV.
Dr. Fierer received his medical degree from Yale University and his Infectious Diseases training at the National Institutes of Health. In 2006, he and his colleagues at Mount Sinai recognized the presence of an epidemic of hepatitis C infection among HIV-infected men-who-have-sex-with-men in New York City. Since that time, Dr. Fierer has become a leader in the investigation of this emerging epidemic in the US and worldwide. His work in the field has included characterizing the rapid onset of liver fibrosis in these men, the behaviors, molecular epidemiology, and body fluids associated with sexual transmission of HCV, and pioneering the use of direct-acting antivirals in the treatment of early HCV infection. His group’s work has been presented at national and international conferences and published in multiple peer-reviewed journals.
On Tuesday, June 18th, Susan Lee, PharmD BCPS CDE, of Northwell Health presented on: “Hepatitis C Medication Prior Authorization”
Dr. Susan M.K. Lee is a specialist pharmacist at the Sandra Atlas Bass Center for Liver Diseases part of Northwell Health. She is a certified diabetes educator and also has a board certification in pharmacy specialties. Since completing her pharmacy residency at North Shore University Hospital, she has been involved with patient care involving diabetes, cardiology, and now hepatitis C management. Dr. Lee currently works with an interdisciplinary team focused on providing access to high cost hepatitis C medications as well as pertinent patient education regarding potential drug interactions, proper medication administration, and appropriate follow up. She has helped over a thousand patients initiate hepatitis C medication regimen.
These learning modules are intended for clinicians of all backgrounds who may encounter or treat patients with hepatitis C and would like to establish core competencies in screening & diagnosis, evaluation and management of the disease. Content includes screening and linkage to care, initial evaluation, diagnosis and recognition of clinical manifestations. These modules were originally presented as a component of the HepCure Tele-Education Webinar Series.
These learning modules are intended for clinicians who have experience treating patients with hepatitis C and would like to further their knowledge. These modules were originally presented as a component of the HepCure Tele-Education Webinar Series.
Psychosocial Readiness Evaluation and Preparation for Hepatitis C Treatment
THe Psychosocial Readiness Evaluation and Preparation for Hepatitis C Treatment (PREP-C) is a free interactive online tool that enables you to provide a thorough assessment of a patient’s psychosocial readiness to begin Hepatitis C treatment, and make a treatment plan to improve treatment readiness.
This free online tool can be used by any type of professional involved in preparing a patient for Hepatitis C Treatment including medical providers, nurses, mental health, substance use, social work, pharmacy, case management, treatment adherence and health education specialists.